LIGASURE™ FAST FACTS
LigaSure™ technology has been used in more than 4 million procedures worldwide.
There are well over 200 published peer-reviewed studies on LigaSure™ technology.
TissueFect™ sensing technology monitors changes in tissue impedance 3,333 times a second, and adjusts energy output accordingly to deliver the appropriate amount of energy for the desired tissue effect.
Valleylab™ mode is responsive energy that helps surgeons manage the tissue effect of surgical devices.
LigaSure™ technology can fuse vessels, including pulmonary vasculature*, up to and including 7 mm, lymphatics and tissue bundles with an average seal cycle of two to four seconds* (*when used with the ForceTriad™ energy platform).
Laparoscopic Hysterectomy
Laparoscopic hysterectomy should be considered when an abdominal hysterectomy is planned or the surgeon anticipates a difficult vaginal hysterectomy. Indications for laparoscopic hysterectomy can include: fibroid uterus less than 16 weeks, presence of severe endometriosis or pelvic adhesions, low-grade uterine malignancies (i.e., well-differentiated adenocarcinoma of the endometrium), adnexal masses with uterine pathology (if ovarian malignancies discovered at laparoscopy, referral to gyn-oncology for definitive surgery).
-
Total laparoscopic hysterectomy
-
Dr. Craig J. Sobolewski
- Duke University Medical Center
- Durham, N.C.
- LigaSure Atlas™ instrument
-
Total laparoscopic hysterectomy
-
Dr. Kevin Stepp
- Case Western Reserve University
- Cleveland, Ohio
- LigaSure Advance™ instrument with ForceTriad™ energy platform
-
Laparoscopically assisted vaginal hysterectomy (LAVH)
-
Dr. John Dulemba
- The Womens Centre
- Denton Regional Medical Center
- Denton, Texas
- LigaSure Atlas™ instrument
-
Laparoscopically assisted vaginal hysterectomy (LAVH)
-
Dr. John Dulemba
- The Womens Centre
- Denton Regional Medical Center
- Denton, Texas
- LigaSure™ Lap instrument
-
Laparoscopically assisted vaginal hysterectomy (LAVH)
-
Dr. John Dulemba
- The Womens Centre
- Denton Regional Medical Center
- Denton, Texas
- LigaSure™ V instrument
-
Laparoscopically assisted vaginal hysterectomy (LAVH)
-
Dr. Rafael G. Juarez
- St. Rose Dominican Hospital
- De Lima Campus
- Las Vegas, Nev.
- LigaSure™ V instrument
-
Laparoscopically assisted vaginal hysterectomy (LAVH)
-
Dr. Anthony Santomauro
- Chief of Laparoscopic GYN Surgery
- Bridgeport Hospital
- Bridgeport, Conn.
- LigaSure™ V instrument
-
Laparoscopic supracervical hysterectomy
-
Dr. Ceana Nezhat
- Director, Nexhat Medical Center
- Center for Special Minimally Invasive Surgery and Reproductive Medicine
- Atlanta, Ga.
-
Laparoscopic supracervical hysterectomy
-
Dr. Joon Park
- Aurora Medical Center
- Kenosha, Wisc.
- LigaSure™ V instrument, Force TriVerse™ electrosurgical device and ForceTriad™ energy platform.
Kim FJ, Chammas MF Jr, Gewehr E, et al. Temperature safety profile of laparoscopic devices: Harmonic ACE (ACE), Ligasure V (LV), and plasma trisector (PT). Surg Endosc. 2008;22(6):1464-1469.
Lamberton GR, Hsi RS, Jin DH, Lindler TU, Jellison FC, Baldwin DD. Prospective comparison of four laparoscopic vessel ligation devices. J Endourol. 2008;22(10):2307-2312.
Newcomb WL, Hope WW, Schmelzer TM, et al. Comparison of blood vessel sealing among new electrosurgical and ultrasonic devices. Surg Endosc. 2009;23(1):90-96.
You are leaving this site and entering a non-Covidien Web site. You will be subject to the destination site's privacy policy when you leave this site.